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WNT10A is a member of the wingless signalling 
pathway that has a fundamental role in skin and ap-
pendageal morphogenesis (1). Moreover, naturally oc-
curring WNT10A gene mutations have been identified 
in the autosomal recessive human ectodermal dysplasia 
syndromes odonto-onycho-dermal dysplasia (OODD; 
OMIM277980) and Schöpf-Schulz-Passarge syndrome 
(SSPS; OMIM224750) (2–7). These disorders show 
considerable phenotypic overlap, with hypodontia, nail 
dystrophy, hypotrichosis and palmoplantar keratoderma 
common to both, although eyelid cysts (apocrine hidro-
cystomas) are thought to be characteristic for SSPS (8). 
Furthermore, variable ectodermal defects (teeth, nails, 
hair) have also been noted in heterozygous carriers of 
WNT10A mutations, with some phenotypic differences 
between males and females: dental anomalies predomi-
nate in males, whereas hair and nail pathology is more 
common in female heterozygotes (4, 7).
CASe RePORTS
In this study we undertook genotype-phenotype correlation in a 
British family with OODD/SSPS, spanning four generations and 
containing seven individuals with diverse ectodermal abnormalities 
(Fig. 1a). One individual (II-2) had the typical clinical features 
of SSPS, including eyelid cysts (Fig. 1b), whereas the others had 
variable ectodermal defects, which are detailed in Table SI (http://
adv.medicaljournals.se/article/abstract/10.2340.00015555-1028). 
Following ethical approval, informed consent, and in accordance 
with the principles of the Declaration of Helsinki, genomic DNA 
from eight available family members was amplified and screened 
for mutations in the WNT10A gene, as described previously. Two 
potentially pathogenic mutations were identified, p.Cys107X and 
p.Phe228Ile (Fig. S1) (http://adv.medicaljournals.se/article/abst-
ract/10.2340.00015555-1028), both of which have been documen-
ted previously in other individuals and families with OODD/SSPS. 
The carrier status for these mutations is depicted in Fig. 1a.
DISCuSSION
Homozygosity for p.Cys107X was detected in individual 
II-2 (male) with clinical features of SSPS. This particular 
mutation appears to be the most common recurrent non-
sense mutation, as it has been reported in nine other pe-
digrees with OODD/SSPS (4, 6, 7). Indeed, it is the most 
frequent molecular pathology in SSPS, notwithstanding 
that it can also underlie OODD, an observation that un-
derscores OODD and SSPS being variable manifestations 
of the same clinicopathological and molecular entity. 
Three individuals in our family who were compound he-
terozygotes for p.Cys107X/p.Phe228Ile showed similar 
but somewhat milder clinical features that were more akin 
to OODD. The missense mutation p.Phe228Ile, which 
is located within a conserved alpha-helix domain of the 
protein, has previously been demonstrated to occur in 
~0.5% of control chromosomes and its occurrence in this 
family appears to have been acquired both through the 
deceased spouse of individual II-2 and the first spouse of 
individual III-2 (individual III-1). There is no history of 
consanguinity in this family, and thus the entrance of this 
mutation at two separate points of the pedigree supports 
the published data that p.Phe228Ile may be a common 
finding in the general population (4, 5). In previous re-
ports, homozygosity for p.Phe228Ile has been associated 
with OODD in one individual, but approximately 50% of 
heterozygotes may show variable abnormalities of skin, 
hair, teeth or nails (4, 5). This observation, based on an as-
sessment of 15 individuals heterozygous for p.Phe228Ile 
and the published control population data, suggests that 
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Fig. 1. (a) Pedigree details showing carrier status for the nonsense/missense 
mutations in WNT10A. (b) Prominent eyelid cysts (apocrine hidrocystomas) 
in individual II-2 characteristic of Schöpf-Schulz-Passarge syndrome. 
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approximately 1 in 400 of the general population may 
manifest some developmental ectodermal defects that are 
directly attributable to this particular missense mutation 
in WNT10A. In our pedigree there were no individuals 
who were solely heterozygous for this mutation, but 
one subject was homozygous for p.Phe228Ile (female, 
IV-2); clinically, there were widely spaced deciduous 
teeth in childhood, but only mild hypodontia and a per-
sisting tendency to overheat as an adult. Two individuals 
who were heterozygous for p.Cys107X (but no other 
WNT10A mutation) displayed very different features: 
one (female, III-4) had eyelid cysts, sparse eyebrows, 
mild hypodontia and slight palmoplantar keratoderma, 
whereas the other (female, IV-3) had no apparent clinical 
anomalies. Although eyelid cysts are a typical feature of 
autosomal recessive SSPS, we noted their presence in 
two other family members, one of whom (III-4) was only 
heterozygous for p.Cys107X and no other mutation in 
WNT10A. Individual III-4 reported multiple eyelid cysts 
similar to those experienced by subject II-2. However, 
these cysts, which developed in her early 30s, lasted for 
only approximately two years and resolved spontaneously 
before detailed clinical or histological assessment was 
feasible. Thus, this clinical feature should perhaps be 
regarded as just one physical sign in the OODD/SSPS 
spectrum rather than a pathognomonic hallmark of SSPS. 
Individuals with SSPS have also been reported to have a 
higher incidence of malignancies, particularly skin can-
cers, although this has not been a universal finding (9). In 
our pedigree, individual II-2 had a history of superficial 
spreading malignant melanoma, cutaneous squamous 
cell carcinoma and basal cell carcinomas, but not internal 
malignancies. No other family member had any history 
of cancer. Dental changes were the most common clini-
cal pathology in our pedigree and were detected in the 
permanent dentition of all homozygotes, all compound 
heterozygotes, and one of the two heterozygotes. The 
severity of the dental abnormalities was more marked in 
males. Individuals II-2 and IV-I had severe hypodontia, 
which was evident in their permanent dentition. Of note, 
subject II-2 required dentures from the age of 14 years 
and subject IV-I retained several deciduous teeth, many 
of which showed extensive root resorption. Individual 
IV-1 also required multiple implant replacement of his 
deciduous teeth, as well as maxillary advancement due to 
mid-facial hypoplasia. Individual III-6 reported hypodon-
tia and wore an upper dental plate. All 3 of these family 
members had conical-shaped teeth. More variable and 
less frequent symptoms/signs in these and other family 
members included hyperhidrosis, nail dystrophy, facial 
erythema and photophobia. Overall, our single pedigree 
study provides a detailed illustration of the phenotypic 
spectrum of ectodermal abnormalities associated with 
WNT10A gene pathology. The findings demonstrate that 
OODD and SSPS are essentially part of the same disorder 
and that the actual clinical manifestations depend not only 
on the presence of one or two mutations in WNT10A, 
the nature of the mutation (nonsense or missense), and 
the sex of an individual, but also on other currently un-
known influences (genetic, epigenetic or environmental) 
that may be relevant to WNT signalling and ectodermal 
homeostasis (10, 11).
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Fig. S1. genomic DNA sequencing. 
(a) Sequencing of family member 
DNA reveals a C > A transversion at 
nucleotide 321 that converts cysteine 
(TgC) to a stop codon (TgA): the 
mutation is designated p.Cys107X 
and homozygous, heterozygous and 
wild-type sequences are illustrated; 
(b) Sequencing of family member 
DNA reveals a T > A transversion 
at nucleotide 682 that converts 
phenylalanine (TTT) to isoleucine 
(ATT): the mutation is designated 
p.Phe228Ile and homozygous, 
heterozygous and wild-type sequences 
are illustrated.
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